Product
Consolidation BuMel
1 clinical trial
1 indication
Indication
Ewing SarcomaClinical trial
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 YearsStatus: Completed, Estimated PCD: 2022-08-01